Concepedia

John M. Hemphill

JM

Statistics

Publications

3

Citations

230

H-Index

3

Active since

2002

Affiliations

Duke University Hospital(Current)

John M. Hemphill is an author at Duke University Hospital specializing in medicine, pharmacology, and developmental-behavioral pediatrics.

Publications per year

2002–2024

3

Publications

3

Safety and efficacy of tolebrutinib, an oral brain-penetrant BTK inhibitor, in relapsing multiple sclerosis: a phase 2b, randomised, double-blind, placebo-controlled trial

Daniel S. Reich, Douglas L. Arnold, Patrick Vermersch et al. · The Lancet Neurology · 2021 · 192 citations · Full text

, , +9

GW320659 for the Treatment of Attention-Deficit/Hyperactivity Disorder in Children

Joseph DeVeaugh-Geiss, C. Keith Conners, Elias Sarkis et al. · Journal of the American Academy of Child & Adolescent Psychiatry · 2002 · 28 citations

, , +9

Case report: Transition from anti-CD20 therapy to inebilizumab for 14 cases of neuromyelitis optica spectrum disorder

Benjamin Osborne, Gabriela Romanow, John M. Hemphill et al. · Frontiers in Neurology · 2024 · 10 citations · Full text

, , +15

1–3 of 3